IGF1 and atherosclerosis: Using an Apolipoprotein E deficient (Apoe-/-) mouse model of atherosclerosis, we have previously demonstrated that IGF-1 exerts anti-atherosclerotic effects in multiple cell types and via multiple mechanisms [38–41].